P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical t...

por Neuberger, M, Paustian, C, Hilton, T, Engel, N, Reu, S, Linder, A, Huber, R, Hatz, R, Winter, H
Publicado 2014

What do Key Stakeholders Think About HIV Self-Testing in Canada? Results from a Cross-Sectional Survey

por Pai, N. Pant, Smallwood, M., Gulati, D., Lapczak, N., Musten, A., Gaydos, C., Johnston, C., Steben, M., Wong, T., Engel, N., Kim, J.
Publicado 2017

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

por van de Berg, S. E. J., Pelzer, P. T., van der Land, A. J., Abdrakhmanova, E., Ozi, A. Muhammad, Arias, M., Cook-Scalise, S., Dravniece, G., Gebhard, A., Juneja, S., Handayani, R., Kappel, D., Kimerling, M., Koppelaar, I., Malhotra, S., Myrzaliev, B., Nsa, B., Sugiharto, J., Engel, N., Mulder, C., van den Hof, S.
Publicado 2021